Literature DB >> 3024884

In vivo activated cytotoxic T cells in the thyroid infiltrate of patients with Hashimoto's thyroiditis.

G F Del Prete, D Vercelli, A Tiri, E Maggi, S Mariotti, A Pinchera, M Ricci, S Romagnani.   

Abstract

High proportions of T8+ cells with inverted T4/T8 ratio were found in freshly isolated thyroid lymphocytes from patients with Hashimoto's thyroiditis. In addition, about one third of thyroid infiltrating cells expressed the TAC antigen, whereas in patient peripheral blood (PB) or normal lymphocytes from PB or lymphoid organs the percentage of TAC-positive cells was consistently lower than 10%. Following negative selection with OKT4 or OKT8 monoclonal antibodies and complement, TAC+ T cells were enriched in the T8+ cell population. Thyroid infiltrating T cells from two patients underwent two different cloning procedures. In the first, single T cells were initially activated with phytohaemagglutinin (PHA) and interleukin 2 (IL-2), in the other with recombinant IL-2 (rIL-2) alone. The majority of T cell clones obtained by initial PHA-stimulation (55-65%) had the T8+ phenotype, but the frequency of T8+ clones obtained by stimulating T cells with rIL-2 alone was even higher (78 & 71%, respectively). The majority of T8+ clones elicited by PHA (35/37 & 36/38) and all the T8+ clones (36/36 & 22/22) obtained from thyroid infiltrates with initial stimulation by rIL-2 displayed cytolytic activity. Most of cytolytic T8+ clones obtained from thyroid infiltrates with both cloning procedures, displayed NK activity against human K562 and MOLT-4 target cells, but not against a NK-resistant target, such as Raji cells. These data suggest that in Hashimoto's disease a considerable proportion of thyroid infiltrating T cells are in vivo activated T8+ cytolytic T cells with NK activity, which may be of importance in determining or maintaining the tissue damage of the target gland.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3024884      PMCID: PMC1542283     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  8 in total

1.  NK and T cell subsets regulate antibody production by human in vivo antigen-induced lymphoblastoid B cells.

Authors:  J A Brieva; S Targan; R H Stevens
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

2.  Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity.

Authors:  A Moretta; G Pantaleo; L Moretta; J C Cerottini; M C Mingari
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

3.  Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from untreated patients with Hodgkin's disease.

Authors:  S Romagnani; G F Del Prete; E Maggi; G Bellesi; G Biti; P L Rossi Ferrini; M Ricci
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

4.  A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor.

Authors:  W J Leonard; J M Depper; T Uchiyama; K A Smith; T A Waldmann; W C Greene
Journal:  Nature       Date:  1982-11-18       Impact factor: 49.962

5.  Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis.

Authors:  C Taswell
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

6.  Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens.

Authors:  L L Lanier; A M Le; J H Phillips; N L Warner; G F Babcock
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

7.  Quantitative assessment of the pool size and subset distribution of cytolytic T lymphocytes within human resting or alloactivated peripheral blood T cell populations.

Authors:  A Moretta; G Pantaleo; L Moretta; M C Mingari; J C Cerottini
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307

8.  Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

Authors:  E A Grimm; A Mazumder; H Z Zhang; S A Rosenberg
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

  8 in total
  5 in total

1.  Immunological events leading to destructive thyroiditis in the AUG rat.

Authors:  R Hassman; N Solic; B Jasani; R Hall; A M McGregor
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

2.  Cytotoxic activity of interleukin-2 (IL-2) activated killer cells toward thyroid epithelial cells.

Authors:  K Migita; K Eguchi; H Tezuka; T Otsubo; A Kawakami; H Nakao; Y Ueki; C Shimomura; M Matsunaga; N Ishikawa
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

3.  The Relationship of Lymphocytic Thyroiditis to the Development of Thyroid Carcinoma.

Authors:  Isao Okayasu
Journal:  Endocr Pathol       Date:  1997       Impact factor: 3.943

Review 4.  Role of apoptosis in autoimmunity.

Authors:  Matilde Todaro; Ann Zeuner; Giorgio Stassi
Journal:  J Clin Immunol       Date:  2004-01       Impact factor: 8.542

Review 5.  Fas-FasL in Hashimoto's thyroiditis.

Authors:  G Stassi; A Zeuner; D Di Liberto; M Todaro; L Ricci-Vitiani; R De Maria
Journal:  J Clin Immunol       Date:  2001-01       Impact factor: 8.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.